Safety Alert for RayStation 2.5, 3.5, 4.0, 4.3, 4.5, 4.7, 4.9, 5, 6, 7

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by RaySearch Laboratories AB.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2018-06-11
  • Event Date Posted
    2018-06-11
  • Event Country
  • Event Source
    DH
  • Event Source URL
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Extra notes in the data
    Medical Device Safety Alert
  • Reason
    Medical device safety alert: raysearch laboratories ab, raystation 2.5, 3.5, 4.0, 4.3, 4.5, 4.7, 4.9, 5, 6, 7 medical device manufacturer, raysearch laboratories ab, has issued a medical device safety alert concerning its raystation 2.5, raystation 3.5, raystation 4.0, raystation 4.3 (inversearc 1.0), raystation 4.5, raystation 4.7, raystation 4.9 (rayplan 1), raystation 5, raystation 6 (rayplan 2) and raystation 7 (rayplan 7) [build number: 2.5.1.89, 3.5.0.16, 3.5.1.6, 4.0.0.14, 4.0.1.4, 4.0.2.9, 4.0.3.4, 4.3.0.14, 4.5.0.19, 4.5.1.14, 4.5.2.7, 4.7.0.15, 4.7.1.10, 4.7.2.5, 4.7.3.13, 4.7.4.4, 4.7.5.4, 4.9.0.42, 5.0.0.37, 5.0.1.11, 5.0.2.35, 6.0.0.24, 6.1.0.26, 6.1.1.2, 6.2.0.7, 7.0.0.19]. it has come to the manufacturer‘s attention that some raystation/rayplan users have commissioned machines with erroneous beam profile correction parameters. these parameters affect the dose calculated in corners of large or off-axis fields. according to the manufacturer, the issue could lead to local under-dosage, potentially leading to in-effective treatment. it is the user’s responsibility to validate the beam model for all clinically relevant fields before the system is used to create clinical treatment plans. the manufacturer’s assessment is that the necessary information is already present in the system labeling, but that it needs to be repeated and highlighted for all affected users, to avoid further mis-use. the safety warnings within the product documentation will be updated in the next version of raystation/rayplan. the affected users are advised to do the following actions: always validate the beam model for all clinically relevant fields, including, but not limited to, large and off-axis fields, before the system is used to create clinical treatment plans. carefully review all beam model parameters before commissioning. be aware that the beam profile correction values may need to be adjusted in order to correctly model the primary collimator that limits the dose in the corners of large or off-axis fields. review any existing photon beam models to ensure that the actions above have been properly performed. educate physics staff about the user responsibilities. according to the local supplier, the affected product is distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 11 june 2018.

Device

  • Model / Serial
  • Product Description
    Medical Device Safety Alert: RaySearch Laboratories AB, RayStation 2.5, 3.5, 4.0, 4.3, 4.5, 4.7, 4.9, 5, 6, 7
  • Manufacturer

Manufacturer